See feature article below:
About Broad Street Alerts:
Big opportunities in Small Cap’s
Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!
February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%
March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.
March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.
April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.
We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
On 4/15/2016, shares of Repros Therapeutics Inc. (NASDAQ:RPRX) fell -14.98% in trading session and finally closed at $2.27. The company most recent volume stood at 8.05 million shares as compared to average volume of 1.83 million shares. Over the one year trading period, the stock has a high price of $8.96 and its low price is recorded at $0.80. The company has a market cap of $55.20M.
During the last trading period, the peak price level of the share was $2.58; it means it is top price of day and down price level of the share was $2.16; it means minimum price of the day at which price share traded.
The corporation generated income of $ 29.20M. The year-to-date performance of the company stands at 87.60 % with increase of 152.22 % in the last week and 118.27 % in the previous three months.
What Analysts Say about Repros Therapeutics Inc.:
The stock has received rating from many Reuters analysts. Currently shares have been rated as “Buy” from 0 Analysts. 0 analysts have suggested “Sell” for the company. 2 analysts have rated the company as a strong “Hold”. Underperform rating was given by 0 analyst and Outperform rating was given by 1 analyst.
The Corporation has a Mean Rating of 2.67 based on the Reuters Analysts consensus issuing ratings.
HCA Holdings, Inc. (NYSE:HCA) showed bearish move with loss of -0.48% after exchanging volume of 3.75 million shares in last trading session ended on 4/15/2016. The company recent traded volume was higher than its average volume of 3.31 million shares. HCA Holdings, Inc. has a P/E and EPS ratio of 16.10and 4.99, respectively. The stock has a consensus analyst price target of $88.36for twelve month. The company finished it is trading at $80.33.
During the 52-week period, the peak price level of the share was observed at $95.49; this is higher price of share and down price level of the share was seen at $43.91; this is lower price at which share is traded.
The company has shown climb of 1.50 % in past 5 days with YTD performance of 18.78 % and 3-month performance up 23.36 %. Net profit margin of the company was 5.40 % while gross profit margin was 83.30 %. The beta value is 1.12.
What Analysts Say about this HCA Holdings, Inc.:
The stock has received rating from many Reuters analysts. Currently shares have been rated as “Buy” from 8 Analysts. 0 analysts have suggested “Sell” for the company. 6 analysts have rated the company as a strong “Hold”. Underperform rating was given by 0 analyst and Outperform rating was given by 10 analyst.
The Corporation has a Mean Rating of 1.92 based on the Reuters Analysts consensus issuing ratings.
Source: Street Updates
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article with exception to FNJN.
Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.